// App-Quantinova.ai

EP509 : EFFICACY AND SAFETY OF MOGAMULIZUMAB BY PATIENT BLOOD CLASSIFICATION

Researchers

Presenter

  • Julia Scarisbrick

Principal Investigators

  • Pier Luigi Zinzani

  • Richard Cowan

  • Jan P. Nicolay

  • Dolores Caballero

  • Lubomir Sokol

  • Lauren Pinter-Brown

  • Jan-Paul Rosen

Medical Centers

  • Institute of Hematology, University of Bologna, Bologna, Italy

  • Christie Hospital and University of Manchester,Manchester,United Kingdom

  • Hospital Universitario De Salamanca-IBSAL, Salamanca, Spain

  • Kyowa Kirin International,Buckinghamshire,United Kingdom

  • Division of Medical Oncology,Moffitt Cancer Center,Tampa,United States

  • University of California Irvine Health Chao Family Comprehensive Cancer Center, Orange, CA

  • University of Birmingham, Birmingham, United Kingdom

  • University Medical Center Mannheim, Mannheim, Germany

Locations

  • Italy

  • United Kingdom

  • Spain

  • United States

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Mogamulizumab

Outcome

  • N/A


Study Design

  • Randomized

  • Cross Over

  • Open Label

Phase

  • III

Study Id's

  • NCT01728805

Sponsors

  • N/A

Result

  • N/A